Evidence that Perutz's double-β-stranded subunit structure for β-amyloids also applies to their channel-forming structures in membranes
暂无分享,去创建一个
[1] L. Lue,et al. Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease , 1999 .
[2] Mark R. Segal,et al. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death , 2004, Nature.
[3] C. Finch,et al. Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers , 2004, The Journal of Neuroscience.
[4] A. Johnston,et al. Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie‐infected murine hippocampus , 2000, Neuropathology and applied neurobiology.
[5] B. Jap. Molecular design of PhoE porin and its functional consequences. , 1989, Journal of molecular biology.
[6] Rushana Azimova,et al. Amyloid Peptide Channels , 2004, The Journal of Membrane Biology.
[7] Karina N. Laohachai,et al. Heterogeneous amyloid-formed ion channels as a common cytotoxic mechanism , 2007, Cell Biochemistry and Biophysics.
[8] D. Salmon,et al. Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.
[9] Pawel Sikorski,et al. New model for crystalline polyglutamine assemblies and their connection with amyloid fibrils. , 2005, Biomacromolecules.
[10] S. Kennedy,et al. Structures of membrane proteins , 1978, The Journal of Membrane Biology.
[11] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[12] T. Morgan,et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] H. Orr,et al. Beyond the Qs in the polyglutamine diseases. , 2001, Genes & development.
[14] C. Gottfries,et al. Membrane Lipids, Selectively Diminished in Alzheimer Brains, Suggest Synapse Loss as a Primary Event in Early‐Onset Form (Type I) and Demyelination in Late‐Onset Form (Type II) , 1994, Journal of neurochemistry.
[15] P. Greengard,et al. Regulation of NMDA receptor trafficking by amyloid-β , 2005, Nature Neuroscience.
[16] H. Minakata,et al. Poly-L-glutamine forms cation channels: relevance to the pathogenesis of the polyglutamine diseases. , 2000, Biophysical journal.
[17] B. Kagan,et al. Polyglutamine‐induced ion channels: a possible mechanism for the neurotoxicity of huntington and other CAG repeat diseases , 2000, Journal of neuroscience research.
[18] G. Schulz,et al. The three‐dimensional structure of porin from Rhodobacter capsulatus at 3 Å resolution , 1990, FEBS letters.
[19] J T Finch,et al. Amyloid fibers are water-filled nanotubes , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[20] Carl W. Cotman,et al. Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.
[21] M. Sheetz,et al. Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[22] R. Mukhopadhyay,et al. Stomatocyte–discocyte–echinocyte sequence of the human red blood cell: Evidence for the bilayer– couple hypothesis from membrane mechanics , 2002, Proceedings of the National Academy of Sciences of the United States of America.